سعر سيكلوكسيميك 500 مجم 30 قرص 2022

Cycloxemic 500 mg 30 f.c. tabs.: Tranexamic acid (Andalous pharma).

• Treatment of cyclic heavy menstrual bleeding (US oral tranexamic acid tablets, e.g. Lysteda-class labeling). Other antifibrinolytic uses exist internationally — confirm Egyptian indication.Population: Adult women with cyclic heavy menstrual bleeding (US label)DailyMed (U.S. National Library of Medicine)

• Headache, sinus/nasal symptoms, back pain, abdominal pain, musculoskeletal pain, arthralgia, muscle cramps, migraine, anemia, fatigue (US oral tranexamic acid).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Combined hormonal contraceptives; active thromboembolic disease or history of thrombosis/thromboembolism; intrinsic risk of thrombosis; hypersensitivity to tranexamic acid (US oral label).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Venous and arterial thrombosis risk; visual/ocular events — discontinue if vision changes; do not use with Factor IX complex concentrates or anti-inhibitor coagulant concentrates; dose-adjust in renal impairment (US label).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Combined hormonal contraceptivesMajorContraindicated — increased thrombotic risk (US oral tranexamic acid).DailyMed (U.S. National Library of Medicine)
• Factor IX complex / anti-inhibitor coagulant concentrates / tissue plasminogen activatorsMajorMay increase thrombosis risk or antagonize thrombolysis (US label).DailyMed (U.S. National Library of Medicine)

• Available data are insufficient to determine drug-associated risk; tranexamic acid crosses placenta — not indicated for use during pregnancy for heavy menstrual bleeding (US label).International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Tranexamic acid is present in human milk; consider maternal need vs infant risk (US label).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Tranexamic acid: Inhibits plasminogen activation / plasmin fibrinolytic activity (UK Cyklokapron SmPC).